Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.
Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
J Gen Intern Med. 2021 Aug;36(8):2378-2385. doi: 10.1007/s11606-021-06924-0. Epub 2021 Jun 7.
The clinical course of COVID-19 includes multiple disease phases. Data describing post-hospital discharge outcomes may provide insight into disease course. Studies describing post-hospitalization outcomes of adults following COVID-19 infection are limited to electronic medical record review, which may underestimate the incidence of outcomes.
To determine 30-day post-hospitalization outcomes following COVID-19 infection.
Retrospective cohort study SETTING: Quaternary referral hospital and community hospital in New York City.
COVID-19 infected patients discharged alive from the emergency department (ED) or hospital between March 3 and May 15, 2020.
Outcomes included return to an ED, re-hospitalization, and mortality within 30 days of hospital discharge.
Thirty-day follow-up data were successfully collected on 94.6% of eligible patients. Among 1344 patients, 16.5% returned to an ED, 9.8% were re-hospitalized, and 2.4% died. Among patients who returned to the ED, 50.0% (108/216) went to a different hospital from the hospital of the index presentation, and 61.1% (132/216) of those who returned were re-hospitalized. In Cox models adjusted for variables selected using the lasso method, age (HR 1.01 per year [95% CI 1.00-1.02]), diabetes (1.54 [1.06-2.23]), and the need for inpatient dialysis (3.78 [2.23-6.43]) during the index presentation were independently associated with a higher re-hospitalization rate. Older age (HR 1.08 [1.05-1.11]) and Asian race (2.89 [1.27-6.61]) were significantly associated with mortality.
Among patients discharged alive following their index presentation for COVID-19, risk for returning to a hospital within 30 days of discharge was substantial. These patients merit close post-discharge follow-up to optimize outcomes.
COVID-19 的临床病程包括多个疾病阶段。描述出院后结局的数据可能有助于了解疾病过程。描述 COVID-19 感染后成年人住院后结局的研究仅限于电子病历审查,这可能低估了结局的发生率。
确定 COVID-19 感染后 30 天的出院后结局。
回顾性队列研究
纽约市的四级转诊医院和社区医院。
2020 年 3 月 3 日至 5 月 15 日期间从急诊科(ED)或医院出院存活的 COVID-19 感染患者。
结局包括出院后 30 天内返回 ED、再住院和死亡。
成功收集了 94.6%符合条件患者的 30 天随访数据。在 1344 名患者中,16.5%返回 ED,9.8%再住院,2.4%死亡。在返回 ED 的患者中,50.0%(108/216)去了与就诊医院不同的医院,61.1%(132/216)返回者再次住院。在使用套索法选择变量的 Cox 模型中,年龄(每增加 1 岁,HR 为 1.01[95%CI 1.00-1.02])、糖尿病(1.54[1.06-2.23])和就诊期间需要住院透析(3.78[2.23-6.43])与再住院率较高独立相关。年龄较大(HR 1.08[1.05-1.11])和亚裔(2.89[1.27-6.61])与死亡率显著相关。
在因 COVID-19 就诊后存活出院的患者中,出院后 30 天内返回医院的风险相当大。这些患者需要密切的出院后随访,以优化结局。